Additional File 3 of Integrative Proteomic Characterization of Trace FFPE Samples in Early-Stage Gastrointestinal Cancer

Lingling Li,Hui Liu,Yan Li,Chunmei Guo,Bing Wang,Dan Shen,Qiao Zhang,Ding Chen

DOI: https://doi.org/10.6084/m9.figshare.19572594

2022-01-01

Abstract:Additional file 3: Supplementary Table S2. Matrix of identified phophoproteins in EESCC and EDAC.

What problem does this paper attempt to address?

Integrative Proteomic Characterization of Trace FFPE Samples in Early-Stage Gastrointestinal Cancer

Lingling Li,Hui Liu,Yan Li,Chunmei Guo,Bing Wang,Dan Shen,Qiao Zhang,Chen Ding

DOI: https://doi.org/10.1186/s12953-022-00188-0

2021-01-01

Abstract:Background: The surveillance and therapy of early-stage cancer would be better for patients' prognosis. However, the extreme trace amount of tissue samples in different stages have limited in portraying the characterization of early-stage cancer. Therefore, we focused on and presented comprehensive proteomic and phosphoproproteomic profiling of the trace FFPE samples from early-stage gastrointestinal cancer, and then explored the potential biomarkers of early-stage gastrointestinal cancer. Methods: In this study, a quantitative proteomic method with chromatography with mass spectrometry (LC-MS/MS) was used to analyse the proteomic difference between the trace early-stage esophageal squamous cell carcinoma (EESCC) and early-stage duodenum adenocarcinoma cancer (EDAC). Results: We identified similar to 6000 proteins and >10,000 phosphosites in single trace FFPE samples. Comparative analysis disclosed the diverse proteomic features of tumor tissues compared with paired normal tissue of EESCC and EDAC, and revealed the difference of EESCC and EDAC was derived from their origin normal tissue. The distinct separation of EESCC and EDAC illustrated the functions of cell cycle (RB1 T373, EGFR T693) in EESCC, and the positive impacts of apoptosis, metabolic processes (MTOR and MTOR 51261) in EDAC. Furthermore, we deconvoluted the immune infiltration of early-stage gastrointestinal cancer, in which higher immune cell signatures were detected in EDAC, and showed the specific cytokines in EESCC and EDAC. We performed kinases-substates relationship analysis and elucidated the specific proteomic kinase characterization of EESCC and EDAC, and proposed the medicative effects and corresponding drugs for EESCC and EDAC at the clinic. Conclusion: We disclosed the specific immune characterization of the early-stage gastrointestinal cancer, and presented potential makers of EESCC (EGFR, PDGFRB, CDK4,WEE1) and EDAC (MTOR, MAP2K1, MAPK3). This study represents a major stepping stone towards investigating the carcinogenesis mechanism of gastrointestinal cancer, and providing a rich resource for medicative strategy in the clinic.
Additional File 4 of Development of a Prognostic Signature of Patients with Esophagus Adenocarcinoma by Using Immune-Related Genes

Xiangxin Zhang,Yang Liu,Ming Kong,Jing Ma,Yongzhong Wei

DOI: https://doi.org/10.6084/m9.figshare.16916421

2021-01-01

Abstract:Additional file 4. Supplement Table 4. The list of differences in the infiltration of 22 immune cell types in the low-and high-risk group of EAC patients.
Identification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissues.

Ling Yao,Weifeng Lao,Yan Zhang,Xiaorong Tang,Xiaotong Hu,Chao He,Xiaofang Hu,Lisa X Xu

DOI: https://doi.org/10.1021/pr300020p

2012-01-01

Journal of Proteome Research

Abstract:Early diagnosis plays a decisive role in the outcome of colorectal cancer (CRC) therapy. The ex vivo culture of fresh CRC tissues and paired normal colorectal tissues provides a feasible way to explore potential serum biomarkers for CRC early detection under near-physiological conditions. In the present work, we applied a lectin affinity based approach to enrich and increase the detection number of secreted proteins in the conditioned media of cultured tissues. The captured proteins were then analyzed by the proteomic strategy of one-dimensional gel electrophoresis coupled to liquid chromatography tandem mass spectrometry. By quantification with label-free spectral counting, we found 123 differentially expressed secreted proteins (DESPs) with 68 DESPs up-regulated in CRC tissues. EFEMP2, one of the top 10 up-regulated DESPs, was further validated by immunohistochemistry at tissue level and enzyme-linked immunosorbent assay at serum level. We found the expression level of EFEMP2 was dramatically increased in CRC patients, even at the early stage. Moreover, the diagnostic accuracy of EFEMP2 was superior to the established CRC biomarker carcinoembryonic antigen evidenced by the area under the receiver operating characteristic curve for the two biomarkers were 0.923 and 0.728, respectively. These results indicated EFEMP2 is a promising serum biomarker for CRC early detection.
LC-MS proteomic profiling of trace FFPE samples in gastrointestinal cancer

Chunmei Guo,Lingling Li,Hui Liu,Chen Ding

DOI: https://doi.org/10.21203/rs.3.rs-1556405/v1

2022-01-01

Abstract:Abstract Background: Early screening and diagnosis of gastrointestinal cancer would be benefit for patients’ prognosis. However, the complexity of cancer progression and the extreme trace amount of tissue samples in different stages have limited in portraying the characterization of early-stage cancer. Here, We disclosed the biological pathways and built an integrated proteomic map of trace FFPE samples in gastrointestinal cancer.Methods: In this study, a quantitative proteomic method with chromatography with mass spectrometry (LC-MS/MS) was used to analyse the different amounts of peptides between the trace duodenum and gastric cancers. Results: We performed a comprehensive proteomic landscape of trace formalin-fixed, paraffin-embedded (FFPE) samples with 5 different amounts of peptides (AOPs) in 40 gastrointestinal cancer samples. Proteomic analysis disclosed the different features of high/low proteins in duodenum and gastric cancers, and revealed the gradually decreased proteins number with the dilutions of AOP. In addition, we found the high coverage of identified proteins when the input of AOPs were no less than 0.5 µg. Proteomic methods represented the loss of tumor heterogeneity when the input of AOPs were no more than 0.5 µg. We also illustrated the dominant pathways in duodenum cancer and gastric cancer, and found the loss function when the input of AOPs was no more than 0.5 µg. Collectively, our study built an integrated proteomic map of trace FFPE samples in gastrointestinal cancer, and provided a valuable resource for clinical researches, especially for early-stage cancer.Conclusion: We disclosed the biological pathways of the trace samples, and revealed the high coverage (> 60%) of identified proteins when the input of AOPs was no less than 0.5 µg, keeping the primary functions of tissues. These findings provided a new insight in early-stage cancer in the clinic.
Supplementary Table 1 from FGFR4 Promotes Stroma-Induced Epithelial-to-Mesenchymal Transition in Colorectal Cancer

Rui Liu,Jingyi Li,Ke Xie,Tao Zhang,Yunlong Lei,Yi Chen,Lu Zhang,Kai Huang,Kui Wang,Hong Wu,Min Wu,Edouard C. Nice,Canhua Huang,Yuquan Wei

DOI: https://doi.org/10.1158/0008-5472.22398246

2023-01-01

Abstract:<p>PDF file, 80K, Differentially expressed proteins identified by 2-DE and MS/MS Analysis.</p>
Additional File 3 of Single-cell Transcriptomic Analysis of Eutopic Endometrium and Ectopic Lesions of Adenomyosis

Yong Li,Zhonghua Sun,Hongyun Liu,Weipin Niu,Xin Wang,Na Liang,Yanfei Wang,Yaxin Shi,Liang Xu,Wei Shi

DOI: https://doi.org/10.6084/m9.figshare.14183843

2021-01-01

Abstract:Additional file 3: Table S2. DEGs of AM_EC vs. AM_EM (all cell types).
Additional File 6 of Proteomic Signatures of 16 Major Types of Human Cancer Reveal Universal and Cancer-Type-specific Proteins for the Identification of Potential Therapeutic Targets

Yangying Zhou,T. Mamie Lih,Jianbo Pan,Naseruddin Höti,Mingming Dong,Liwei Cao,Yingwei Hu,Cho,Shao‐Yung Chen,Rodrigo Vargas Eguez,Edward Gabrielson,Daniel W. Chan,Hui Zhang,Qing Kay Li

DOI: https://doi.org/10.6084/m9.figshare.13346607

2020-01-01

Abstract:Additional file 6: Table S5. Cancer-associated proteins related to Fig. 4, Fig. 5, Figure S4, and Figure S5.
Supplementary Figure 3 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Lingling Li,Dongxian Jiang,Hui Liu,Chunmei Guo,Qiao Zhang,Xuedong Li,Xiaojian Chen,Zheqi Chen,Jinwen Feng,Subei Tan,Wen Huang,Jie Huang,Chen Xu,Chen-Ying Liu,Wei Yu,Yingyong Hou,Chen Ding

DOI: https://doi.org/10.1158/0008-5472.26934688

2024-01-01

Abstract:Supplementary Figure 3 and related legend of the revised manuscript.
Integrative proteogenomic characterization of early esophageal cancer

Lingling Li,Dongxian Jiang,Qiao Zhang,Hui Liu,Fujiang Xu,Chunmei Guo,Zhaoyu Qin,Haixing Wang,Jinwen Feng,Yang Liu,Weijie Chen,Xue Zhang,Lin Bai,Sha Tian,Subei Tan,Chen Xu,Qi Song,Yalan Liu,Yunshi Zhong,Tianyin Chen,Pinghong Zhou,Jian-Yuan Zhao,Yingyong Hou,Chen Ding

DOI: https://doi.org/10.1038/s41467-023-37440-w

IF: 16.6

2023-03-25

Nature Communications

Abstract:Abstract Esophageal squamous cell carcinoma (ESCC) is malignant while the carcinogenesis is still unclear. Here, we perform a comprehensive multi-omics analysis of 786 trace-tumor-samples from 154 ESCC patients, covering 9 histopathological stages and 3 phases. Proteogenomics elucidates cancer-driving waves in ESCC progression, and reveals the molecular characterization of alcohol drinking habit associated signatures. We discover chromosome 3q gain functions in the transmit from nontumor to intraepithelial neoplasia phases, and find TP53 mutation enhances DNA replication in intraepithelial neoplasia phase. The mutations of AKAP9 and MCAF1 upregulate glycolysis and Wnt signaling, respectively, in advanced-stage ESCC phase. Six major tracks related to different clinical features during ESCC progression are identified, which is validated by an independent cohort with another 256 samples. Hyperphosphorylated phosphoglycerate kinase 1 (PGK1, S203) is considered as a drug target in ESCC progression. This study provides insight into the understanding of ESCC molecular mechanism and the development of therapeutic targets.

multidisciplinary sciences
Additional File 3 of Identification of Novel Prognostic Biomarkers by Integrating Multi-Omics Data in Gastric Cancer

Nannan Liu,Yun Wang,Weipeng Cheng,Yuxuan Wu,Liguo Wang,Zhuang Liu

DOI: https://doi.org/10.6084/m9.figshare.14490337

2021-01-01

Abstract:Additional file 3. Contains 4 TFs and 5 miRNAs were confirmed by enrichment.
Additional File 3 of Elevated Expression of LPCAT1 Predicts a Poor Prognosis and is Correlated with the Tumour Microenvironment in Endometrial Cancer

Tianyi Zhao,Min Han,Xiaohong Ma,Lina Wei,Yixin Hou,Rui Sun,Jie Jiang

DOI: https://doi.org/10.6084/m9.figshare.14633808

2021-01-01

Abstract:Additional file 3: Table S1. Immune scores and stromal scores of EC.
Supplementary Figure 4 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Lingling Li,Dongxian Jiang,Hui Liu,Chunmei Guo,Qiao Zhang,Xuedong Li,Xiaojian Chen,Zheqi Chen,Jinwen Feng,Subei Tan,Wen Huang,Jie Huang,Chen Xu,Chen-Ying Liu,Wei Yu,Yingyong Hou,Chen Ding

DOI: https://doi.org/10.1158/0008-5472.26934685.v1

2024-01-01

Abstract:Supplementary Figure 4 and related legend of the revised manuscript.
Supplementary Figure 2 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Lingling Li,Dongxian Jiang,Hui Liu,Chunmei Guo,Qiao Zhang,Xuedong Li,Xiaojian Chen,Zheqi Chen,Jinwen Feng,Subei Tan,Wen Huang,Jie Huang,Chen Xu,Chen-Ying Liu,Wei Yu,Yingyong Hou,Chen Ding

DOI: https://doi.org/10.1158/0008-5472.26934691

2024-01-01

Abstract:Supplementary Figure 2 and related legend of the revised manuscript.
Supplementary Figure 5 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Lingling Li,Dongxian Jiang,Hui Liu,Chunmei Guo,Qiao Zhang,Xuedong Li,Xiaojian Chen,Zheqi Chen,Jinwen Feng,Subei Tan,Wen Huang,Jie Huang,Chen Xu,Chen-Ying Liu,Wei Yu,Yingyong Hou,Chen Ding

DOI: https://doi.org/10.1158/0008-5472.26934682.v1

2024-01-01

Abstract:Supplementary Figure 5 and related legend of the revised manuscript.
Supplementary Figure 3 from FGFR4 Promotes Stroma-Induced Epithelial-to-Mesenchymal Transition in Colorectal Cancer

Rui Liu,Jingyi Li,Ke Xie,Tao Zhang,Yunlong Lei,Yi Chen,Lu Zhang,Kai Huang,Kui Wang,Hong Wu,Min Wu,Edouard C. Nice,Canhua Huang,Yuquan Wei

DOI: https://doi.org/10.1158/0008-5472.22398255

2023-01-01

Abstract:PDF file, 1780K, Proteomic analysis of RKO cells co-cultured with TAFs.
N-linked glycoproteomic profiling in esophageal squamous cell carcinoma

Qi-Wei Liu,Hao-Jie Ruan,Wei-Xia Chao,Meng-Xiang Li,Ye-Lin Jiao,Douglas G Ward,She-Gan Gao,Yi-Jun Qi

DOI: https://doi.org/10.3748/wjg.v28.i29.3869

IF: 5.374

2022-08-07

World Journal of Gastroenterology

Abstract:BACKGROUND: Mass spectrometry-based proteomics and glycomics reveal post-translational modifications providing significant biological insights beyond the scope of genomic sequencing.AIM: To characterize the N-linked glycoproteomic profile in esophageal squamous cell carcinoma (ESCC) <i>via</i> two complementary approaches.METHODS: Using tandem multilectin affinity chromatography for enrichment of N-linked glycoproteins, we performed N-linked glycoproteomic profiling in ESCC tissues by two-dimensional gel electrophoresis (2-DE)-based and isobaric tags for relative and absolute quantification (iTRAQ) labeling-based mass spectrometry quantitation in parallel, followed by validation of candidate glycoprotein biomarkers by Western blot.RESULTS: 2-DE-based and iTRAQ labeling-based quantitation identified 24 and 402 differentially expressed N-linked glycoproteins, respectively, with 15 in common, demonstrating the outperformance of iTRAQ labeling-based quantitation over 2-DE and complementarity of these two approaches. Proteomaps showed the distinct compositions of functional categories between proteins and glycoproteins with differential expression associated with ESCC. Western blot analysis validated the up-regulation of total procathepsin D and high-mannose procathepsin D, and the down-regulation of total haptoglobin, high-mannose clusterin, and GlcNAc/sialic acid-containing fraction of 14-3-3ζ in ESCC tissues. The serum levels of glycosylated fractions of clusterin, proline-arginine-rich end leucine-rich repeat protein, and haptoglobin in patients with ESCC were remarkably higher than those in healthy controls.CONCLUSION: Our study provides insights into the aberrant N-linked glycoproteome associated with ESCC, which will be a valuable resource for future investigations.

gastroenterology & hepatology
Supplementary Figure 6 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Lingling Li,Dongxian Jiang,Hui Liu,Chunmei Guo,Qiao Zhang,Xuedong Li,Xiaojian Chen,Zheqi Chen,Jinwen Feng,Subei Tan,Wen Huang,Jie Huang,Chen Xu,Chen-Ying Liu,Wei Yu,Yingyong Hou,Chen Ding

DOI: https://doi.org/10.1158/0008-5472.26934679

2024-01-01

Abstract:Supplementary Figure 6 and related legend of the revised manuscript.
Supplementary Figure 8 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Lingling Li,Dongxian Jiang,Hui Liu,Chunmei Guo,Qiao Zhang,Xuedong Li,Xiaojian Chen,Zheqi Chen,Jinwen Feng,Subei Tan,Wen Huang,Jie Huang,Chen Xu,Chen-Ying Liu,Wei Yu,Yingyong Hou,Chen Ding

DOI: https://doi.org/10.1158/0008-5472.26934673.v1

2024-01-01

Abstract:Supplementary Figure 8 and related legend of the revised manuscript.
Supplementary Figure 10 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Lingling Li,Dongxian Jiang,Hui Liu,Chunmei Guo,Qiao Zhang,Xuedong Li,Xiaojian Chen,Zheqi Chen,Jinwen Feng,Subei Tan,Wen Huang,Jie Huang,Chen Xu,Chen-Ying Liu,Wei Yu,Yingyong Hou,Chen Ding

DOI: https://doi.org/10.1158/0008-5472.26934694

2024-01-01

Abstract:Supplementary Figure 10 and related legend of the revised manuscript.
Supplementary Table 2 from FGFR4 Promotes Stroma-Induced Epithelial-to-Mesenchymal Transition in Colorectal Cancer

Rui Liu,Jingyi Li,Ke Xie,Tao Zhang,Yunlong Lei,Yi Chen,Lu Zhang,Kai Huang,Kui Wang,Hong Wu,Min Wu,Edouard C. Nice,Canhua Huang,Yuquan Wei

DOI: https://doi.org/10.1158/0008-5472.22398243

2023-01-01

Abstract:PDF file, 71K, Clinico-pathologic parameters of colorectal cancer patients.

Additional File 3 of Integrative Proteomic Characterization of Trace FFPE Samples in Early-Stage Gastrointestinal Cancer

Integrative Proteomic Characterization of Trace FFPE Samples in Early-Stage Gastrointestinal Cancer

Additional File 4 of Development of a Prognostic Signature of Patients with Esophagus Adenocarcinoma by Using Immune-Related Genes

Identification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissues.

LC-MS proteomic profiling of trace FFPE samples in gastrointestinal cancer

Supplementary Table 1 from FGFR4 Promotes Stroma-Induced Epithelial-to-Mesenchymal Transition in Colorectal Cancer

Additional File 3 of Single-cell Transcriptomic Analysis of Eutopic Endometrium and Ectopic Lesions of Adenomyosis

Additional File 6 of Proteomic Signatures of 16 Major Types of Human Cancer Reveal Universal and Cancer-Type-specific Proteins for the Identification of Potential Therapeutic Targets

Supplementary Figure 3 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Integrative proteogenomic characterization of early esophageal cancer

Additional File 3 of Identification of Novel Prognostic Biomarkers by Integrating Multi-Omics Data in Gastric Cancer

Additional File 3 of Elevated Expression of LPCAT1 Predicts a Poor Prognosis and is Correlated with the Tumour Microenvironment in Endometrial Cancer

Supplementary Figure 4 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Supplementary Figure 2 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Supplementary Figure 5 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Supplementary Figure 3 from FGFR4 Promotes Stroma-Induced Epithelial-to-Mesenchymal Transition in Colorectal Cancer

N-linked glycoproteomic profiling in esophageal squamous cell carcinoma

Supplementary Figure 6 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Supplementary Figure 8 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Supplementary Figure 10 from Comprehensive Proteogenomic Profiling Reveals the Molecular Characteristics of Colorectal Cancer at Distinct Stages of Progression

Supplementary Table 2 from FGFR4 Promotes Stroma-Induced Epithelial-to-Mesenchymal Transition in Colorectal Cancer